RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

BIBLIOGRAFÍA
Treatment of High Blood Pressure. JNC 7-complete version.
Hypertension: 42: 1206-52, 2003.
31. European best practice guidelines for hemodialysis (Part 1).
Nephrol Dial Transplant: 17 (Suppl 7): S1 – S109, 2002.
32. European best practice guidelines for renal transplantation
(Part 2). Nephrol Dial Transplant: 17 (Suppl 4): S1 – S67,
2002.
33. World Health Organization, International Society of
Hypertension Writing Group. 2003 World Health
Organization/International Society of Hypertension statement
on management of hypertension J Hypertens 2003: 21:
1983-1992.
34. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT,
Potter JF y cols. British Hypertension Society guidelines for
hypertension management 2004 (BHS-IV):summary. BMJ
328: 634-40, 2004.
35. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C,
Cifkova R, Dallongeville J y cols. European guidelines on
cardiovascular disease prevention in clinical practice. Eur
Heart J: 24: 1601-1610, 2003.
36. Guía sobre el diagnóstico y el tratamiento de la hipertensión
arterial en España 2002. Hipertensión: 19 (Supl 3): S1-S74.
Actualizada a 1-03-2003 en http://www.seh-lelha.org/, 2002
37. Brotons C, Royo-Bordonada MA, Álvarez-Sala L, Armario P,
Artigao R, Conté P y cols. Adaptación española de la guía
europea de prevención cardiovascular. Nefrología 24: 312-
28,2004.
38. López Bescós L, Arós Borau F, Lidón Corbi RM Cequier
Fillat A, Bueno H, Alonso JJ, y cols. Actualización (2002)
de las Guías de Práctica Clínica de la Sociedad Española de
Cardiología en angina inestable /infarto sin elevación del
segmento ST. Rev Esp Cardiol: 55: 631 – 642. 2002.
39. Guía de práctica clínica sobre hipertensión arterial. Servicio
Vasco de Salud. Vitoria, pp1-106, 2002.
40. Peters NS, Schilling RJ, Kanagaratnam P, Markides V. Atrial
fibrillation: strategies to control, combat, and cure. Lancet:
359: 593-630, 2002.
41. Antithrombotic Trialists’ Collaboration. Collaborative metaanalysis
of randomised trials of antiplatelet therapy for prevention
of death, myocardial infarction, and stroke in high
risk patients. BMJ: 324: 71-86, 2002.
42. Executive summary oh the third report of the National
Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III). JAMA: 285:
2486-2497, 2001.
43. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman
AM, Francis GS y cols. ACC/AHA Guidelines for the
Evaluation and Management of Chronic Heart Failure in the
Adult: Executive Summary. Circulation: 104: 2996-3007,
2001.
44. Cain AE, Khalil RA: Pathophysiology of essential hypertension:
role of the pump, the vessel, and the kidney. Semin
Nephrol 22: 3-16, 2002.
45. Oparil S, Zaman MA, Calhoun DA: Pathogenesis of hypertension.
Ann Intern Med 139: 761-776, 2003.
46. Ritz E, Adamczak M, Zeier M: Kidney and hypertension-causes.
Update 2003. Herz 28: 663-667, 2003.
47. Cusi D, Barlassina C, Taglietti MV: Genetics of human hypertension.
J Nephrol 16: 609-615, 2003.
48. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ:
Oxidative stress, renal infiltration of immune cells, and saltsensitive
hypertension: all for one and one for all. Am J
Physiol Renal Physiol 286: F606-F616, 2004.
49. Weinberger MH: Salt sensitivity of blood pressure in
humans. Hypertension 27: 481-490, 1996.
50. Hall JE: The kidney, hypertension, and obesity. Hypertension
41 (3 Pt 2): 625-633, 2003.
51. K/DOQI clinical practice guidelines on hypertension and
antihypertensive agents in chronic kidney disease: Executive
summary. Am J Kidney Dis 43 (Suppl 1): S16-S41, 2004.
52. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of
cardiovascular disease in chronic renal disease. Am J Kidney
Dis 32 (Suppl 3): S112-S119, 1998.
53. Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine
RJ, y cols: Mild renal insufficiency is associated with increased
cardiovascular mortality: the Hoorn study. Kidney Int
62: 1402-1407, 2002.
54. Locatelli F, Bommer J, London GM, Martín-Malo A, Wanner
C, Yaqoob M, y cols: Cardiovascular disease determinants in
chronic renal failure: clinical approach and treatment.
Nephrol Dial Transplant 16: 459-468, 2001.
55. Prichard S: Risk factors for coronary artery disease in patients
with renal failure. Am J Med Sci 325: 209-213, 2003.
56. Zoccali C, Mallamaci F, Tripepi G: Traditional and emerging
cardiovascular risk factors in end-stage renal disease. Kidney
Int Suppl: 63 (Suppl 85):S105-S110; 2003.
57. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J:
The prevalence of non-traditional risk factors for coronary
heart disease in patients with chronic kidney disease. Ann
Intern Med 140: 9-17; 2004.
58. Kasiske BL: Cardiovascular disease after renal transplantation.
Semin Nephrol 20: 176-187; 2000.
59. Tyralla K, Amann K: Morphology of the heart and arteries in
renal failure. Kidney Int Suppl: 63 (Suppl 84):S80-S83, 2003.
60. Amann K, Tyralla K, Gross ML, Eifert T, Adamczak M, Ritz E:
Special characteristics of atherosclerosis in chronic renal failure.
Clin Nephrol 60 (suppl 1): S13-21, 2003.
61. Safar ME, London GM, Plante GE: Arterial stiffness and kidney
function. Hypertension 43: 163-168, 2004.
62. London GM: Left ventricular alterations and end-stage renal
disease. Nephrol Dial Transplant 17 (Suppl 1): 29-36, 2002.
63. Campistol JM: Uremic myopathy. Kidney Int 62: 1901-1913,
2002.
64. London GM: Cardiovascular disease in chronic renal failure:
pathophysiologic aspects. Semin Dial 16: 85-94, 2003.
65. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PWF, Levy
D: Predictors of new-onset kidney disease in a communitybased
population. JAMA 291: 844-850, 2004.
66. Chen J, Muntner P, Hamm LH, Jones DW, Batuman V,
Fonseca V, y cols. The metabolic syndrome and chronic kidney
disease in U.S. adults. Ann Intern Med 140: 167-174,
2004.
67. Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk
KA, y cols. Accuracy of the diagnosis of hypertensive nephrosclerosis
in African Americans: a report from the African
American Study of Kidney Diseases (AASK). Kidney Int 51:
244-252, 1997.
188